Get started
Author

Raymond Henderson

Observed names: Henderson, Raymond, Henderson, Raymond H, Henderson, Raymond H., R Henderson, Raymond H Henderson, Raymond H. Henderson, Raymond Hugo Henderson
ORCID: 0000-0002-2127-8533
Observed ORCID: 0000-0002-2127-8533
OpenAlex ID: A5065697847
The genetics and screening of familial hypercholesterolaemia
2016 · Raymond Henderson, Maurice O’Kane, et al. · Journal of Biomedical Science · 156
PDF
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
2021 · Raymond Hugo Henderson, Declan French, et al. · The Lancet. Gastroenterology & hepatology · 102
PDF
Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems
2021 · Nicola Normanno, Kathi Apostolidis, et al. · Seminars in Cancer Biology · 71
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach
2023 · Raymond H. Henderson, Declan French, et al. · Journal of Pharmaceutical Policy and Practice · 27
PDF
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
2022 · Xavier G.L.V. Pouwels, Christopher J. Sampson, et al. · Value in Health · 26
PDF
Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review
2021 · Raymond Henderson, Peter Keeling, et al. · Molecular Oncology · 24
PDF
Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses
2019 · Raymond Henderson, Declan French, et al. · Oncotarget · 19
PDF
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report
2025 · Raymond H. Henderson, Chris Sampson, et al. · Value in Health · 8
Shooting for the Moon or Flying Too Near the Sun? Crossing the Value Rubicon in Precision Cancer Care
2016 · Mark Lawler, Declan French, et al. · Public Health Genomics · 7
Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer
2022 · Raymond H. Henderson, Declan French, et al. · Journal of Cancer Policy · 6
PDF
Pcv9: Cost-effectiveness of Eptifibatide in the Uk Based on Pursuit Trial
2001 · RE Brown, J Hutton, et al. · Value in Health · 2
PDF
Economic burden of not testing for FLT3 to treat acute myeloid leukemia.
2020 · Raymond Henderson, Dave Smart, et al. · Journal of Clinical Oncology · 1
Healthcare costs associated with overweight and obesity in Ireland
2026 · Sean Fennessy, Raymond H Henderson, et al. · Endocrine Abstracts
EE702 The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review
2025 · Raymond H. Henderson, Sandra Redmond, et al. · Value in Health
Meeting Abstract: OC8 Healthcare costs associated with overweight and obesity in Ireland
2025 · Fennessy, Seán, Henderson, Raymond H, et al. · Research Portal (Queen's University Belfast)
Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020
2022 · Dave Smart, Wendy L Allen, et al. · Cancer Research
Effect of COVID-19 Pandemic Control Measures on Diagnoses of Hematologic Cancer Among CMS Population in 2020
2021 · Dave Smart, Wendy Moore, et al. · Blood
Does the precision oncology medicine development pathway deliver value for health systems?
2021 · Raymond Henderson, Declan French, et al. · Journal of Clinical Oncology
Evaluating cost effectiveness of precision cancer medicine approaches and the economic burden of colorectal cancer
2019 · Raymond Henderson · Research Portal (Queen's University Belfast)
PDF
Molecular biomarkers and precision medicine in colorectal cancer: Value for Money?
2018 · Raymond Henderson, Mike Clarke, et al. · Research Portal (Queen's University Belfast)
Title Page / Table of Contents
2016 · Denis Horgan, Declan French, et al. · Public Health Genomics
PDF
Works count: 27
Citation count: 449
H-index: 8
I10-index: 7
Year
Topic
Type